Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Reconstructive Surgery Trials Network

Current Grant support


Blond McIndoe Research Foundation


Dunhill Medical Trust

National Institute of Health Research

Royal College of Surgeons of England

Matthew Gardiner

MA PhD FRCS(Plast)

Honorary Departmental Clinical Lecturer in Plastic and Reconstructive Surgery

  • Surgical Specialty Lead for Plastic Surgery, RCS Clinical Trials Initiative

Surgical Trials

I co-founded the Reconstructive Surgery Trials Network (RSTN) with Prof. Abhilash Jain in 2013. The RSTN is the UK clinical trials network for plastic surgery and hand surgery. It has over 600 members from undergraduates through to consultants and trials methodologists. 

The RSTN has developed many interdisciplinary collaborations to deliver a diverse range of projects. My main interest is clinical trials relating to hand surgery and in particular developing placebo arm RCTs. Visit for further information. 


As part of the ARUK Centre for OA Pathogenesis, I work with Prof Tonia Vincent on translational projects relating to base of thumb osteoarthritis. This has led to collaborations with groups at University of Leeds (Drs Pete Culmer and Ali Alazmani) and Imperial College London (Dr Angela Kedgley).

MSc Surgical Science and Practice

I am co-director of the Health Innovation and Technology module. Further details regarding the course are here.


I read physiological sciences as an undergraduate at Fitzwilliam College, University of Cambridge before moving to Oriel College, University of Oxford to complete my clinical training.

In 2011, I completed a PhD at the Kennedy Institute of Rheumatology, Imperial College London. This focused on the molecular changes that occur during the initiation and early progression of osteoarthritis (OA).